PURPOSE: Peripheral neuropathy has been shown to exist in prediabetic and diabetic patients and animal models. However, the development of peripheral neuropathy in prediabetes and posthyperglycemia is likely different. The purpose of this study was to examine the progression of peripheral neuropathy in diet-induced obese rats and high-fat-fed rats treated with a low dose of streptozotocin, a model for type 2 diabetes, using standard endpoints as well as corneal sensitivity and innervation. METHODS: Diet-induced obese rats and high-fat/low-dose streptozotocin diabetic rats were used to examine standard peripheral neuropathy endpoints and innervation of the cornea and corneal epithelium using corneal and standard confocal microscopy, respectively, and corneal sensitivity using a Cochet-Bonnet esthesiometer at three different time points. RESULTS: Obese rats and to a greater extent diabetic rats were insulin resistant. Obese and diabetic rats had developed sensory nerve deficits, but only diabetic rats had motor nerve dysfunction as determined by measuring nerve conduction velocity, thermal nociception, and intraepidermal nerve fiber density. In the cornea there was a decrease in corneal nerve fiber length, innervation of the corneal epithelium, and corneal sensitivity in both diet-induced obese and diabetic rats. CONCLUSIONS: These studies demonstrate that changes in corneal nerve innervation and sensitivity occur in both obese and type 2 diabetic rat models that are consistent with development of peripheral neuropathy. Examination of corneal nerve changes may be valuable endpoints for exploring potential treatments for peripheral neuropathy in both prediabetes with insulin resistance and diabetes.
PURPOSE:Peripheral neuropathy has been shown to exist in prediabetic and diabeticpatients and animal models. However, the development of peripheral neuropathy in prediabetes and posthyperglycemia is likely different. The purpose of this study was to examine the progression of peripheral neuropathy in diet-induced obeserats and high-fat-fed rats treated with a low dose of streptozotocin, a model for type 2 diabetes, using standard endpoints as well as corneal sensitivity and innervation. METHODS: Diet-induced obeserats and high-fat/low-dose streptozotocindiabeticrats were used to examine standard peripheral neuropathy endpoints and innervation of the cornea and corneal epithelium using corneal and standard confocal microscopy, respectively, and corneal sensitivity using a Cochet-Bonnet esthesiometer at three different time points. RESULTS:Obeserats and to a greater extent diabeticrats were insulin resistant. Obese and diabeticrats had developed sensory nerve deficits, but only diabeticrats had motor nerve dysfunction as determined by measuring nerve conduction velocity, thermal nociception, and intraepidermal nerve fiber density. In the cornea there was a decrease in corneal nerve fiber length, innervation of the corneal epithelium, and corneal sensitivity in both diet-induced obese and diabeticrats. CONCLUSIONS: These studies demonstrate that changes in corneal nerve innervation and sensitivity occur in both obese and type 2 diabeticrat models that are consistent with development of peripheral neuropathy. Examination of corneal nerve changes may be valuable endpoints for exploring potential treatments for peripheral neuropathy in both prediabetes with insulin resistance and diabetes.
Authors: R A Malik; P Kallinikos; C A Abbott; C H M van Schie; P Morgan; N Efron; A J M Boulton Journal: Diabetologia Date: 2003-05-09 Impact factor: 10.122
Authors: Mitra Tavakoli; Cristian Quattrini; Caroline Abbott; Panagiotis Kallinikos; Andrew Marshall; Joanne Finnigan; Philip Morgan; Nathan Efron; Andrew J M Boulton; Rayaz A Malik Journal: Diabetes Care Date: 2010-04-30 Impact factor: 19.112
Authors: Christine L Oltman; Eric P Davidson; Lawrence J Coppey; Travis L Kleinschmidt; Donald D Lund; Mark A Yorek Journal: Obesity (Silver Spring) Date: 2008-01 Impact factor: 5.002
Authors: Debbie K Chen; Katie E Frizzi; Lucie S Guernsey; Kelsey Ladt; Andrew P Mizisin; Nigel A Calcutt Journal: J Peripher Nerv Syst Date: 2013-12 Impact factor: 3.494
Authors: Irina G Obrosova; Fei Li; Omorodola I Abatan; Mark A Forsell; Katalin Komjáti; Pal Pacher; Csaba Szabó; Martin J Stevens Journal: Diabetes Date: 2004-03 Impact factor: 9.461
Authors: Ioannis N Petropoulos; Uazman Alam; Hassan Fadavi; Omar Asghar; Patrick Green; Georgios Ponirakis; Andrew Marshall; Andrew J M Boulton; Mitra Tavakoli; Rayaz A Malik Journal: Diabetes Care Date: 2013-07-22 Impact factor: 19.112
Authors: Brian Fink; Lawrence Coppey; Eric Davidson; Hanna Shevalye; Alexander Obrosov; Pratik Rajesh Chheda; Robert Kerns; William Sivitz; Mark Yorek Journal: Free Radic Res Date: 2020-04-24
Authors: Krisandra Kneer; Michael B Green; Jenna Meyer; Celeste B Rich; Martin S Minns; Vickery Trinkaus-Randall Journal: Exp Eye Res Date: 2018-06-05 Impact factor: 3.467
Authors: Matthew S Yorek; Alexander Obrosov; Hanna Shevalye; Sergey Lupachyk; Matthew M Harper; Randy H Kardon; Mark A Yorek Journal: J Peripher Nerv Syst Date: 2014-09 Impact factor: 3.494